During the past decade, RDC Global Pty Ltd conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "RDC Global Pty Ltd" are "Alzheimer Disease" (1 trials), "Eczema, Atopic" (1 trials), "Migraine" (1 trials), "Optimal Gastrointestinal Absorption of Omega-3" (1 trials) and "Osteopenia" (1 trials). Many other conditions were trialed in "RDC Global Pty Ltd" in a lesser frequency.

Most popular intervention types in "RDC Global Pty Ltd" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "1.5% Palmitoylethanolamide (PEA) sold as Levagen+" (1 trials), "AC-OLE-01-VA" (1 trials), "Medical Food SBD111" (1 trials), "Palmitoylethanolamide sold as Levagen +" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "RDC Global Pty Ltd" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "RDC Global Pty Ltd". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in RDC Global Pty Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in RDC Global Pty Ltd, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".